Neurogenic Dysphagia Clinical Trial
— FEES-RegistryOfficial title:
Findings and Side-effects of Flexible Endoscopic Evaluation of Swallowing - the FEES-Registry
NCT number | NCT03037762 |
Other study ID # | 01072014 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 2014 |
Est. completion date | October 2017 |
Verified date | November 2019 |
Source | University Hospital Muenster |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. The FEES-Registry aims at evaluating findings and side effects of FEES in a heterogeneous collective of patients with neurogenic dysphagia.
Status | Completed |
Enrollment | 2401 |
Est. completion date | October 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - suspected neurogenic dysphagia - Patients being scheduled for a FEES - written informed consent Exclusion criteria: - none |
Country | Name | City | State |
---|---|---|---|
Germany | University Hospital | Muenster |
Lead Sponsor | Collaborator |
---|---|
University Hospital Muenster |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | FEES-related side effects - 1. systolic blood pressure increase | Systolic blood pressure will be measured directly prior, during and after the procedure. The initial value will be compared to the highest blood pressure value measured during/directly after the procedure. | during the procedure | |
Primary | FEES-related side effects - 2. Oxygen saturation decline | Oxygen saturation will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure. | during the procedure | |
Primary | FEES-related side effects - 3. Heart rate decrease | Heart rate will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure. | during the procedure | |
Primary | FEES-related side effects - 4. Nose bleed | Number of patients with nose bleed during the procedure | during the procedure | |
Primary | FEES-related side effects - 5. Laryngospasm | Number of patients with laryngospasm during the procedure | during the procedure | |
Primary | FEES-related side effects - 6. Decreased level of consciousness | Number of patients with a decline in consciousness during the procedure (measured with the Richmond agitation and sedation scale) | during the procedure | |
Primary | Patients subjective FEES-related discomfort | Number of patients with procedure related discomfort measured with a 4 point scale ranging from 1=no discomfort to 4=extremely painful sensation during the procedure | during the procedure | |
Secondary | Changes of dietary status after FEES | Dietary status will be assessed directly prior to the procedure and immediately thereafter. Dietary status will be assessed with the Functional Oral Intake Scale (FOIS scale). | immediately prior and immediately after the procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02493491 -
Neurogenic Dysphonia/Dysphagia Registry
|
N/A | |
Completed |
NCT01995929 -
Functional Endoscopy in Neurogenic Dysphagia
|
||
Recruiting |
NCT05190718 -
Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia
|
||
Completed |
NCT03241615 -
Dysphagia Symptom Severity and Quality of Life
|
||
Completed |
NCT05782790 -
Action Observation Therapy Program in Patients With Neurogenic Dysphagia
|
N/A |